Review

Clinical significance of miRNAs and exosomal miRNAs in non-small cell lung cancer: diagnostic, prognostic, and therapeutic perspectives.

Imteyaz A. Khan Surabhi Gupta J. Meena

Aug 2026 · Journal of Human Genetics · 0 citations · 211 references

Medicine

TL;DR

This review summarizes the diagnostic, prognostic, predictive, and therapeutic potential of tissue-derived, circulating, and exosomal miRNAs in NSCLC and discusses the major challenges limiting the clinical translation of miRNA-based biomarkers and therapeutics.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Sep 2026

The miR105/767 cluster as a coordinator of apoptosis and PD-L1 expression in non-small cell lung cancer

Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality, largely due to late diagnosis, molecular diversity, and frequent development of treatment resistance. MicroRNAs (miRNAs) play critical roles in NSCLC initiation, progression, and treatment resistance. Previous studies have ide...

Maryam Abdipourbozorgbaghi, R. Radpour, S. Haefliger · Cancer Cell International · 0 citations

Review Open access Sep 2026

The Role of KRAS in Non-Small Cell Lung Cancer: From Molecular Background to Precision Medicine

The complexity of KRAS biology in NSCLC is highlighted and the importance of integrating molecular, epigenetic, and therapeutic insights to advance precision medicine and improve clinical outcomes is underscored.

Jadwiga Gaździcka, K. Gołąbek · International Journal of Mol... · 0 citations

Review 2026

Non-coding RNAs related to PD1/PD-L1 signaling with potential diagnostic, prognostic, and therapeutic value in the tumorigenesis of brain cancers

A review of recent advances in understanding the regulatory role of ncRNAs on the PD-1/ PD-L1 pathway in brain cancer tumorigenesis highlights promising opportunities for developing therapeutic interventions against brain cancer.

Reihane Behnam-Rassouli, Farzaneh Entezari, Majid Ghorbanzadeh et al. · Iranian Journal of Basic Med... · 0 citations

Review Open access Sep 2026

Circulating MicroRNAs in non-small cell lung cancer: Clinical potential, analytic pitfalls, and barriers to implementation

Background Neoadjuvant chemoimmunotherapy is standard care for resectable non-small cell lung cancer (NSCLC), yet 70% to 80% of patients do not achieve a pathologic complete response, and no validated biomarker identifies likely non-responders before or during treatment. Circulating microRNAs (miRNAs) have been propose...

I. Augustin, Adelina Birceanu, L. Mazilu et al. · The journal of liquid biopsy · 0 citations

Review Open access Sep 2026

Non-coding RNAs in tumor-educated platelets: emerging roles in cancer progression, biomarker discovery, and therapeutic targeting

Non-coding RNAs (ncRNAs) in tumor-educated platelets (TEPs) play an important role in cancer progression. Tumor cells can “educate” platelets, thereby enabling them to participate in multiple stages of tumor development and progression. The ncRNAs carried by TEPs, including microRNAs (miRNAs), circular RNAs (circRNAs),...

Ya-Ning Liu, Yu-Cheng Zhang, Dong-Ni Li et al. · Frontiers in Oncology · 0 citations

Review Open access Aug 2026

Emerging Roles of MicroRNAs in Diffuse Large B-Cell Lymphoma: From Molecular Mechanisms to Clinical Translation, Liquid Biopsy, and Precision Medicine

Diffuse large B-cell lymphoma (DLBCL), the most prevalent subtype of non-Hodgkin lymphoma (NHL), is an aggressive and fairly heterogeneous group with diverse clinical, pathological, and molecular features. Despite the success of first-line immunochemotherapy, relapsed or treatment-resistant forms remain a clinical chal...

Corina Joldes, Laura Jimbu, O. Mesaros et al. · Biomedicines · 0 citations